Jennifer Sexton

• Products Jardiance, Synjardy, and Zepbound
• MVP Award for 2025
• Developed and executed strategic sales plans to increase market share for Jardiance, Synjardy and Zepbound.
• Built strong relationships with healthcare providers to enhance product visibility and patient education initiatives.
• District analytics team leader for 2025, Peer to Peer program leader for 2024
• District diabetes educator/trainer
• Multiple STEM visits for district
• Mentored junior sales specialists on effective selling techniques, supporting their professional development within the organization.
• Collaborated with cross-functional teams(Boehringer Ingelheim & Eli Lily) for successful product launches, leading to increased market share.
• 17 out 18 quarters over 100% to goal

Individual territory, promoting Velphoro, for Renal Therapies division to Nephrologists/Dialysis Clinics

• Strengthened relationships with current accounts through consistent and frequent communication.
• Secured high-value accounts through consultative selling, effective customer solutions and promoting compelling business opportunities.
• Increased market share by 5% for territory with limited sales opportunity with proactive account servicing and diligent relationship-building during Covid.
• Collaborated with associates and developed relationships within dialysis clinics; including dieticians, clinic managers, social works and lead RN's
• Successfully gained sales through supporting clinics to utilize prior authorization program to increase marketshare and reduce loss of prescriptions
• Developed independent day to day practices resourcing peers and director as needed

• Motivated to exceed my goals and delivery clinical information for customers to prescribe product to change patients lives
• In charge of individual territory promoting ADHD products Quillivant, Quillichew, and Dyanavel To Psychiatrist, Pediatrician, and Primary Care
• Rapid and consistent growth; Territory ranked in bottom initially and by end of first quarter in territory ranked 35/130
• Quarter 3 ranking was 31/130
• Effectively pulled prescriptions thru at pharmacy level with Scheduled II products over a highly generic market

• Promoted respiratory pharmaceuticals to physicians, including Pulmonologists; products Anoro, Incruse, Breo
• Developed productive relationships with customers and staff to increase market share
• Organized, executed marketing initiatives and maintain positive market share growth with in my territory
• Developed successful business plan to increase NRx market share within territory
• Increased market share 30% to end market share of29.9%
• Finished contract with territory ranked #2 out of 10 in region
• Proficient in Veeva/Salesforce CRM, Concur, WebEx, MMIT formulary software

• Responsible for launching Sprivia 1.25mcg for uncontrolled asthma in large territory covering Grand Rapids and Lansing MI
• Achieved 69% growth in first 4 weeks with a net sales of over $14,000
• Currently increased total sales(TRx) by 69%
• Increased new sales( NRx) at 67%
• New to area and immediately adapted to territory with impact of sales (rx) in 2 weeks
• Adapted to changing situations by analyze markets and account for continued immediate growth
• Implementing corporate marketing strategies which resulted in 69% growth in launch
• Teamwork to targeted customers to build stronger relationship with customers

Responsible for respiratory products - Advair

• Achieved assigned sales objectives for this territory. Organized territory/account to maximize sales impact and finished with market share of 52%
• Review and analyze market data for developing and implementing GSK goals to targeted customers
• District Respiratory Expert - presented and worked with district peers to help gain respiratory marketplace knowledge. Developed strategies to increase market share during prim allergy seasons
• Regional Microstrategy Expert - introduce new sales analytics program to region
• First year review received 125% to target bonus

• Achieved #1 out of 74 representative in nation end contract
• Responsible for Nexium & Entocort ER to gastroenterologists
• Individually responsible for managing large Chicago territory
• Achieved 116% to goal in 4th quarter 2014, ranking 15 out of 74 in the nation
• Consecutive quarters in 2013-2014 above 100% of goal
• Ranked in top 10% for 2nd, 3rd and 4th quarters 2013
• Developed solid relationships with office staff and physicians to drive new prescription growth in a highly generic marketplace
• Trained district representatives new software programs and computer champion
• Increased market share 3 out 4 quarters in largely generic market 2011-2012
• Identified top clients and increased their market share by 10% every quarter in largely generic market where manage care dictates generic failure first
• New hire mentor

• Developed business relations with targeted physicians for asthma respiratory pharmaceuticals Qvar/ProAir In large territory
• Exceeded target goal for primary product, ProAir HFA by 115% for 3 out of 4 quarters 2009 increasing market share of 2%-8% over Ventolin in extremely competitive market
• Identified new market segments and expanded existing customer base in under performing territory, increasing market share by over 20% Top 25% of all sales representative for primary product 2009
• Arranged and provide continuing education and service to targeted physicians, saving them time and cost
• Marketed informative sales presentations based on individual customer needs to maximize market share
• Selected to be clinical advisor for competitive product education to district teammates